Endoscopy

8K Technology Market to witness an Exponential Growth of 45.5% CAGR by 2031 as Demand from Advertising & Entertainment Industry is on Rise - Persistence Market Research

Retrieved on: 
Wednesday, December 1, 2021
NTT Data, NHK, Table, Television, ViewSonic, Technology, PMR, AI, CAGR, Partnership, Education, Shoe, NTT, Sony, K, Endoscopy, Artificial intelligence, Advertising, Panasonic, Electronics, Full, Association, PDF, Lens, Growth, Fertilizer, Online shopping, Fine chemical

8K technology offers ultra-high-definition image of 33 million pixels, which is 16 times more detailed than 2K (Full HD) images.

Key Points: 
  • 8K technology offers ultra-high-definition image of 33 million pixels, which is 16 times more detailed than 2K (Full HD) images.
  • 8K-resolution display technology has been used in endoscopy, medical monitoring, remote medical diagnosis, and educational display of surgical operations.
  • Furthermore, 8K ultra-high definition image technology has lucrative opportunities when used for remote surgery combined with 5G mobile networks.
  • Main sources of 8K content include 8K streaming, 8K personal videos, 8K video gaming, and upscale content.

Surgio Health and DARVIS Partner to Deliver Transformative Healthcare Solutions That Improve Operating Room Efficiencies Through AI and Machine Learning Technology

Retrieved on: 
Tuesday, November 30, 2021
Hygiene, CEO, Technology, Software as a service, Endoscopy, Hospital, Surgeon, Partnership, SPD, Diving, HIPAA, Percussion section, Workflow, COO, Solution, OR, Data Analytics Acceleration Library, Artificial intelligence, Machine learning, GLOBE, Sterilization, Healthcare Facilities Accreditation Program, EHR, Documentation, Platform as a service, Medical device

Together, the two are diving into creating innovative instrument tracking and optimization solutions utilizing optical recognition and machine learning technology.

Key Points: 
  • Together, the two are diving into creating innovative instrument tracking and optimization solutions utilizing optical recognition and machine learning technology.
  • With the use of computer vision technology, healthcare providers can now easily track objects such as surgical instruments, no matter how small.
  • - Jan Schlueter, COO, DARVIS
    "Surgio is very excited to partner with DARVIS for the development of transformative Artificial Intelligence through optical recognition and machine learning solutions.
  • DARVIS solutions help transform hospitals and healthcare organizations into intelligent autonomous environments that enable healthcare professionals to deliver better and safer patient-centric care.

Iterative Scopes CE Marks SKOUT, its Innovative AI-Based Medical Device for Potential Colorectal Polyps Detection

Retrieved on: 
Tuesday, November 30, 2021
Research, Technology, Other Technology, Clinical Trials, Software, Other Health, Biotechnology, Pharmaceutical, Health, Science, Patient, MIT, Sale, Technology, Gastroenterology, Disease, CE, European Union, MBBS, Precision medicine, MDD, GI, Medical Device Regulation Act, VP, IBD, Goal, Inflammatory bowel disease, Gastrointestinal disease, Colorectal cancer, Adult, Marketing, Endoscopy, Massachusetts Institute of Technology, Colorectal polyp, Union, Colonoscopy, Harvard University, Growth, Adenoma, Medical device, Medical imaging

Iterative Scopes is pioneering the application of precision medicine to gastroenterology with the aim of enhancing colorectal cancer screenings.

Key Points: 
  • Iterative Scopes is pioneering the application of precision medicine to gastroenterology with the aim of enhancing colorectal cancer screenings.
  • Iterative Scopes is initially applying these advances to improve polyp detection for colorectal cancer screenings and standardizing disease severity characterization for inflammatory bowel disease (IBD).
  • 1 The medical device can validly be CE marked and commercialized in the European Union under the transitional provisions of the Medical Devices Regulation which started to apply on 26 May 2021.
  • It is not intended to provide primary interpretation of endoscopic procedures, medical diagnosis, or recommendations of treatment/course of action for patients.

Ambu Awarded National Video Laryngoscope Contract with Vizient Inc.

Retrieved on: 
Monday, November 29, 2021
Health, Medical Devices, Technology, Surgery, Other Health, Audio, Video, General Health, Patient, Laryngoscopy, Anesthesia, Asia, CEO, Safety, Endoscopy, Hospital, Ambu, Contract, Solution, Airway management, Twitter, Nursing, Efficiency, Intubation, Life, LinkedIn, Inc., Multimedia, YouTube, Video game console

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    The contract covers Ambus King Vision video laryngoscope system, which enables quick and easy intubation with a display providing a consistent clear real-time view of a patients airway.
  • The contract also includes Ambus next-generation video laryngoscope, which is expected to launch in 2022.
  • The agreement creates a Video Laryngoscope category specifically for the Vizient membership, effective January 1, 2022, and gives members pre-negotiated pricing and terms for Ambus full suite of video laryngoscopy products.
  • Ambu will now be able to boost market share in the hospital market, the largest healthcare segment in Video Laryngoscopes.

Fujifilm Launches the Velocity MRI System at RSNA 2021

Retrieved on: 
Monday, November 29, 2021
Patient, OEM, Magnetic resonance imaging, RSNA, Claustrophobia, Google Images, Diagnosis, Workflow, Solution, Laboratory, Fujifilm, Velocity, GLOBE, Endoscopy, Enterprise imaging, McCormick Place, MRI, Knowledge, CT, Mammography, Medical imaging

Lexington, Mass., USA, Nov. 29, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic imaging and medical informatics solutions, announced it will unveil the Velocity MRI System, its advanced, high-field open MRI system during the 2021 Radiological Society of North America (RSNA) conference, booth #1911 (South Hall), from November 28 - December 2, 2021 at McCormick Place in Chicago.

Key Points: 
  • Lexington, Mass., USA, Nov. 29, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic imaging and medical informatics solutions, announced it will unveil the Velocity MRI System, its advanced, high-field open MRI system during the 2021 Radiological Society of North America (RSNA) conference, booth #1911 (South Hall), from November 28 - December 2, 2021 at McCormick Place in Chicago.
  • The Velocity MRI system is Fujifilms newest MRI scanner, designed to streamline workflow and enhance the patient experience with its unique open gantry, integrated radiofrequency (RF) coils and reconstruction technologies.
  • Velocity defines what todays true Open MRI is about the unique patient comfort and accommodation benefits of open-sided MRI now joined by the workflow and image quality benefits of integrated RF coils and enhanced reconstruction technologies, said Shawn Etheridge, Director, CT and MRI Marketing for FUJIFILM Healthcare Americas Corporation.
  • To learn more about Fujifilms Velocity MRI system, request a virtual or in-person demo at RSNA here.

$39.47 Bn Endoscopy Devices Markets - Global Forecast to 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 24, 2021
Medical Devices, Health, Patient, Tissue, Adoption, Safety, Endoscopy, AI, CAGR, Awareness, Diagnosis, Cancer, Prevalence, Barrett's esophagus, IBD, Inflammatory Bowel Diseases, Obesity, Incidence, Arthritis, Artificial intelligence, Medical imaging, Medical device

The "Endoscopy Devices Global Market - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endoscopy Devices Global Market - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • Due to persistently escalating prevalence, and incidence of chronic diseases across the globe, and the need for early diagnostic, and therapeutic interventions, increasing inclination of patients towards the minimally invasive therapeutic procedures, gradual transition of endoscopy devices market towards single-use endoscopes, the emergence of technologically advanced endoscopy products, the trend of acquisitions, and collaborations in the endoscopy device industry, and the increasing awareness, and adoption of the highly beneficial endoscopic procedures across the emerging nations.
  • Endoscopy is a minimally invasive or non-invasive medical procedure that utilizes specialized devices like endoscopes for the detailed inspection or assessment, and manipulation or treatment of diseased organs or tissues by visualizing the internal organ or area of interest.
  • The constantly advancing various emergency or elective endoscopy procedures are being used for the timely diagnosis, and minimally-traumatic treatment of various chronic ailments like cancer, arthritis, joint injuries, inflammatory bowel diseases (IBD), chronic pancreatitis, obesity, Barrett's esophagus, and others.

Fujifilm launches ColoAssist PRO, a real-time endoscope visualisation system which aims to help endoscopists perform efficient, accurate and comfortable colonoscopies

Retrieved on: 
Wednesday, November 24, 2021
Patient, Polyp (medicine), Endoscopy, Time, Technology, AI, Diagnosis, Cancer, Ultra, Decision-making, Moncton Hospital, Solution, CAD, Vaccine, Photography, PRO, Physician, Quality of life, Research, Colorectal cancer, Incidence, Health, Efficiency, Colonoscopy, Intubation, Regenerative medicine, European Business Awards for the Environment, Percussion section, EYE, Medical device, Medical imaging

DÜSSELDORF, Germany, Nov. 24, 2021 /PRNewswire/ -- Fujifilm has launched ColoAssist PRO, a real-time endoscope visualisation system, designed to assist endoscopists in performing colonoscopies.

Key Points: 
  • Endoscopists are facing increased demand due to the growing incidence of colorectal cancer across Europe.
  • The need for efficient, accurate and comfortable endoscopic procedures is thus essential for both clinicians and their patients.
  • With its image centering function, endoscopists can perform procedures without losing sight of the graphical endoscope position.
  • It enhances Fujifilm's existing ELUXEO system by incorporating ColoAssist PRO, our real-time endoscope visualisation system to deliver a comprehensive package for endoscopists.

Fujifilm to Showcase Expanded Medical Imaging Portfolio at the RSNA 2021 Conference

Retrieved on: 
Tuesday, November 23, 2021
Exhibition, Heart, Lung, OEM, Radiology, CEO, Sale, Cristal Festival Europe, Magnetic resonance imaging, Technology, RSNA, FDR, Google Images, Diagnosis, Tomosynthesis, Cardiology, Solution, Laboratory, Fujifilm, Spine, History, OR, Persona, ICU, ER, Velocity, DBT, GLOBE, Endoscopy, Enterprise imaging, MRI, Artifact, Digital, Knowledge, FDA, CT, Mammography, Pharmaceutical industry, Medical imaging

Lexington, Mass., USA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation announced it will showcase its portfolio of medical imaging solutions at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, held November 28 - December 2, 2021 at McCormick Place West in Chicago.

Key Points: 
  • Lexington, Mass., USA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation announced it will showcase its portfolio of medical imaging solutions at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, held November 28 - December 2, 2021 at McCormick Place West in Chicago.
  • This is the companys first RSNA exhibition since integrating FUJIFILM Medical Systems U.S.A., Inc. and Hitachi Healthcare Americas on October 1, 2021.
  • Fujifilms medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy, and endosurgery.
  • The Synapse Enterprise Imaging portfolio provides healthcare professionals with the imaging and data access needed to deliver a complete patient record.

Fujifilm’s REiLI® Artificial Intelligence Platform Now in Clinical Use for Intracranial Hemorrhage and Breast Cancer Detection and Diagnosis

Retrieved on: 
Tuesday, November 23, 2021
Patient, ICH, OEM, Radiology, Adoption, Workload, Magnetic resonance imaging, Technology, RSNA, AI, Digital Mammographic Imaging Screening Trial, Death, Diagnosis, Woman, URG, Intracranial hemorrhage, Workflow, Bleeding, Solution, 2D, Fujifilm, Breast cancer, Laboratory, Reily Foods Company, 3D, Artificial intelligence, Capital Health, Disability, Survival, Health, Incidence, Endoscopy, Enterprise imaging, GLOBE, Knowledge, Efficiency, Vascular disease, Traumatic brain injury, Triage, Survivor, Mammography, Disease, Life, Stroke, Synapse, Medical device, Medical imaging

With traumatic brain injury and stroke, early detection and treatment of hemorrhage leads to improved outcomes and can mean the difference between life and death.

Key Points: 
  • With traumatic brain injury and stroke, early detection and treatment of hemorrhage leads to improved outcomes and can mean the difference between life and death.
  • Mammographers at URG access Transpara through Fujifilms REiLI platform to support their detection and diagnosis of breast cancer.
  • New studies find that the use of AI in breast cancer screening could reduce the workload of radiologists by up to 70%, without reducing cancer detection.
  • REiLI, Fujifilms artificial intelligence initiative, combines Fujifilms rich image -processing heritage with cutting-edge AI innovations to inspire a new tier of clinical confidence.

Fujifilm Showcases Enhanced Synapse® Enterprise Imaging Portfolio at RSNA 2021

Retrieved on: 
Tuesday, November 23, 2021
Cloud, Patient, OEM, Radiology, Magnetic resonance imaging, RSNA, EIS, Cardiology, Diagnosis, Partnership, Solution, Laboratory, Tebenna inspirata, GLOBE, Health, Enterprise imaging, Endoscopy, Knowledge, Efficiency, Mammography, RIS, PACS, 1989 Tiananmen Square protests, Pathology, Medical imaging

Lexington, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- November 23, 2021 - FUJIFILM Healthcare Americas Corporation announced it will showcase advancements to its Synapse Enterprise Imaging portfolio at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, from November 28 - December 2, 2021 at McCormick Place West in Chicago.

Key Points: 
  • Lexington, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- November 23, 2021 - FUJIFILM Healthcare Americas Corporation announced it will showcase advancements to its Synapse Enterprise Imaging portfolio at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, from November 28 - December 2, 2021 at McCormick Place West in Chicago.
  • We continue to advance our Synapse Enterprise Imaging portfolio to unify imaging and expand data access across the entire healthcare enterprise, said Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation At RSNA 2021, were excited to unveil a number of Synapse software enhancements that drive cross-departmental collaboration, workflow efficiency and more-informed clinical decision making.
  • Synapse Cloud Services , which provides a scalable and secure environment to host and manage the Synapse Enterprise Imaging portfolio.
  • The Synapse Enterprise Imaging portfolio provides healthcare professionals with the imaging and data access needed to deliver a complete patient record.